A 24-Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients

Tsubakihara, Y; Akizawa, T; Nangaku, M; Onoue, T; Yonekawa, T; Matsushita, H; Endo, Y; Cobitz, A

Matsushita, H (reprint author), GlaxoSmithKline, Akasaka Interc AIR, Japan Dev & Med Affairs, Med Dev,Minato Ku, 1-8-1 Akasaka, Tokyo 1070052, Japan.

THERAPEUTIC APHERESIS AND DIALYSIS, 0; ():

Abstract

Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor developed for treating anemia of chronic kidney disease. This 24-week, ph......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索